These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25902902)

  • 1. A novel cardioprotective mechanism of exogenous nitric oxide: inhibition of Rho-associated kinase activity.
    Tanaka A; Node K
    Hypertens Res; 2015 Jul; 38(7):461-2. PubMed ID: 25902902
    [No Abstract]   [Full Text] [Related]  

  • 2. Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial.
    Maruhashi T; Noma K; Fujimura N; Kajikawa M; Matsumoto T; Hidaka T; Nakashima A; Kihara Y; Liao JK; Higashi Y
    Hypertens Res; 2015 Jul; 38(7):485-90. PubMed ID: 25740292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antianginal and anti-ischemic effects of Mono Mac 50D preparation as an agent in combined treatment of patients with stable angina].
    Demchenko EA; Berezina AV; Panov AV
    Klin Med (Mosk); 2002; 80(9):57-9. PubMed ID: 12416229
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of the blood oxygen transport function in patients with angina pectoris receiving treatment correcting the L-arginine-NO pathway].
    Zinchuk VV; Dobrodeĭ MA; Lis MA
    Fiziol Cheloveka; 2008; 34(2):136-8. PubMed ID: 18472585
    [No Abstract]   [Full Text] [Related]  

  • 5. LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodeling.
    Paulis L; Simko F
    Hypertension; 2007 Dec; 50(6):1009-11. PubMed ID: 17984370
    [No Abstract]   [Full Text] [Related]  

  • 6. [ECG and BP monitoring in patients with stable angina and essential hypertension on therapy with monocinque].
    Zaslavskaia RM; Shcherban' EA; Logvinenko SI
    Klin Med (Mosk); 2005; 83(10):19-21. PubMed ID: 16320839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality of life of patients with ischemic heart disease taking isosorbide-5-mononitrate in an outpatient setting].
    Popov KV; Kuimov AD
    Kardiologiia; 2003; 43(7):53-4. PubMed ID: 14603907
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of long-term administration of isosorbide 5-mononitrate (Mononit), nitric oxide donor, on gallbladder emptying in patients with chronic stable angina].
    Hamankiewicz M; Kucio C; Czapla J; Wójcik P
    Wiad Lek; 2001; 54(3-4):137-42. PubMed ID: 11436678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of international study of quality of life of patients with stable angina treated with nitrates (IQOLAN)].
    Belenkov IuN; Chazova IE; Ratova LG; Dmitriev VV; Lebedeva NA; Pavlov VE; Bishele NA; Demura SA
    Kardiologiia; 2003; 43(9):4-7. PubMed ID: 14593363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide and squamous carcinoma.
    Brennan PA
    J Oral Maxillofac Surg; 2003 Feb; 61(2):277. PubMed ID: 12619013
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endothelium and nitric oxide].
    Garaliene V
    Medicina (Kaunas); 2008; 44(7):564-9. PubMed ID: 18695354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do we still need organic nitrates?
    Münzel T; Wenzel P; Daiber A
    J Am Coll Cardiol; 2007 Mar; 49(12):1296-8. PubMed ID: 17394961
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term therapy with organic nitrates: the pros and cons of nitric oxide replacement therapy.
    Gori T; Parker JD
    J Am Coll Cardiol; 2004 Aug; 44(3):632-4. PubMed ID: 15358032
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nitric oxide and heart failure].
    Yoshioka T; Takahashi M; Ikeda U
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():527-30. PubMed ID: 15506442
    [No Abstract]   [Full Text] [Related]  

  • 15. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.
    Zell R; Markgraf R; Schmidtke M; Görlach M; Stelzner A; Henke A; Sigusch HH; Glück B
    Med Microbiol Immunol; 2004 May; 193(2-3):91-100. PubMed ID: 14513374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isosorbide dinitrate for treatment of preterm labor.
    Haghighi L; Akbarian A
    Int J Gynaecol Obstet; 2005 Jun; 89(3):274-5. PubMed ID: 15919396
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical use of nitric oxide donors and L-arginine in obstetrics.
    de Pace V; Chiossi G; Facchinetti F
    J Matern Fetal Neonatal Med; 2007 Aug; 20(8):569-79. PubMed ID: 17674274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy.
    Thomson AJ; Lunan CB; Ledingham M; Howat RC; Cameron IT; Greer IA; Norman JE
    Lancet; 1998 Oct; 352(9134):1093-6. PubMed ID: 9798584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient cervical ripening before first-trimester surgical abortion: a comparison between misoprostol and isosorbide mononitrate.
    Radulovic N; Norström A; Ekerhovd E
    Acta Obstet Gynecol Scand; 2007; 86(3):344-8. PubMed ID: 17364311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.